Cytostatic drug treatment causes seeding of gene promoter methylation.

about

Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer Broad targeting of resistance to apoptosis in cancer.The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum.

P2860

Q27030815-4D856445-0AA6-45CC-8360-51F5AE94C9E0 Q36483749-E0B663D6-A0BD-4C2C-862A-266E131BAB18 Q37493907-C2171AA8-C617-4A3B-93AA-EE96AB6C274C

P2860

Cytostatic drug treatment causes seeding of gene promoter methylation.

Item

http://www.wikidata.org/entity/Q36725766

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Cytostatic drug treatment causes seeding of gene promoter methylation.

@ast

Cytostatic drug treatment causes seeding of gene promoter methylation.

@en

type

Item

label

Cytostatic drug treatment causes seeding of gene promoter methylation.

@ast

Cytostatic drug treatment causes seeding of gene promoter methylation.

@en

prefLabel

Cytostatic drug treatment causes seeding of gene promoter methylation.

@ast

Cytostatic drug treatment causes seeding of gene promoter methylation.

@en

P1476

Cytostatic drug treatment causes seeding of gene promoter methylation.

@en

P2093

Anders Bredberg

http://www.w3.org/2001/XMLSchema#string

P2860

Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines

Epigenetics as a mechanism driving polygenic clinical drug resistance

Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer

Epigenetic variation in Arabidopsis disease resistance

Epigenetic programming in the preimplantation rat embryo is disrupted by chronic paternal cyclophosphamide exposure.

HPRT: gene structure, expression, and mutation.

DNA methylation and epigenetic inheritance.

Role of the promoter in maintaining transcriptionally active chromatin structure and DNA methylation patterns in vivo.

Epigenetics and the environment.

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.

P304

947-954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJCA.2006.12.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Walter Bodmer

P577

2007-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6565818

http://www.w3.org/2001/XMLSchema#string

P698

17236756

http://www.w3.org/2001/XMLSchema#string

P932

2430383

http://www.w3.org/2001/XMLSchema#string

Cytostatic drug treatment causes seeding of gene promoter methylation.

about

P2860

P2860

Cytostatic drug treatment causes seeding of gene promoter methylation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932